| Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions R Marullo, E Werner, N Degtyareva, B Moore, G Altavilla, SS Ramalingam, ... PloS one 8 (11), e81162, 2013 | 785 | 2013 |
| THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors F Cayrol, P Praditsuktavorn, TM Fernando, N Kwiatkowski, R Marullo, ... Nature communications 8 (1), 14290, 2017 | 103 | 2017 |
| HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer … R Marullo, E Werner, H Zhang, GZ Chen, DM Shin, PW Doetsch Carcinogenesis 36 (11), 1397-1406, 2015 | 101 | 2015 |
| Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas B Culjkovic-Kraljacic, TM Fernando, R Marullo, N Calvo-Vidal, A Verma, ... Blood, The Journal of the American Society of Hematology 127 (7), 858-868, 2016 | 93 | 2016 |
| Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients B Pera, T Tang, R Marullo, SN Yang, H Ahn, J Patel, R Elstrom, J Ruan, ... Clinical Epigenetics 8, 1-10, 2016 | 44 | 2016 |
| Combination therapy targeting BCL6 and phospho-STAT3 defeats intratumor heterogeneity in a subset of non–small cell lung cancers D Deb, S Rajaram, JE Larsen, PD Dospoy, R Marullo, LS Li, K Avila, ... Cancer research 77 (11), 3070-3081, 2017 | 41 | 2017 |
| BCL6 evolved to enable stress tolerance in vertebrates and is broadly required by cancer cells to adapt to stress TM Fernando, R Marullo, B Pera Gresely, JM Phillip, SN Yang, ... Cancer discovery 9 (5), 662-679, 2019 | 39 | 2019 |
| Metabolomic profiling reveals cellular reprogramming of B-cell lymphoma by a lysine deacetylase inhibitor through the choline pathway B Pera, J Krumsiek, SE Assouline, R Marullo, J Patel, JM Phillip, L Román, ... EBioMedicine 28, 80-89, 2018 | 30 | 2018 |
| The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases R Marullo, M Castro, S Yomtoubian, MN Calvo-Vidal, MV Revuelta, ... Science advances 7 (45), eabg1964, 2021 | 25 | 2021 |
| Oncogenic HSP90 facilitates metabolic alterations in aggressive B-cell lymphomas MN Calvo-Vidal, N Zamponi, J Krumsiek, MA Stockslager, MV Revuelta, ... Cancer research 81 (20), 5202-5216, 2021 | 21 | 2021 |
| Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma E Ricker, A Verma, R Marullo, S Gupta, C Ye, T Pannellini, M Manni, ... Scientific Reports 10 (1), 13094, 2020 | 10 | 2020 |
| Procedure for developing linear and Bayesian classification models based on immunosensor measurements S Mobley, S Yalamanchili, H Zhang, R Marullo, ZG Chen, CS Moreno, ... Sensors and Actuators B: Chemical 190, 165-170, 2014 | 9 | 2014 |
| Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas R Marullo, SC Rutherford, JP Leonard, L Cerchietti Cell Cycle 15 (17), 2241-2247, 2016 | 5 | 2016 |
| Abstract LB-062: XPO1 is a rational target for double and triple-hit aggressive B-cell lymphomas R Marullo, SN Yang, T Rashal, Y Landesman, R Carlson, S Shacham, ... Cancer research 75 (15_Supplement), LB-062-LB-062, 2015 | 5 | 2015 |
| XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells R Marullo, SC Rutherford, MV Revuelta, N Zamponi, B Culjkovic-Kraljacic, ... Cancer Research 84 (1), 101-117, 2024 | 4 | 2024 |
| A phase I study of selinexor and R-ICE in patients with relapsed/refractory aggressive B-cell lymphomas SC Rutherford, JN Allan, J Ruan, RR Furman, K Richards, A Rodriguez, ... Blood 136, 7-8, 2020 | 4 | 2020 |
| Inhibition of integrin αVβ3 signaling improves the antineoplastic effect of bexarotene in cutaneous T-cell lymphoma F Cayrol, MV Revuelta, M Debernardi, A Paulazo, JM Phillip, N Zamponi, ... Molecular cancer therapeutics 21 (9), 1485-1496, 2022 | 3 | 2022 |
| The transcription factor BCL6 is a rational target in non-small cell lung cancer (NSCLC) R Marullo, H Ahn, M Cardenas, A Melnick, F Xue, L Cerchietti Cancer Research 76 (14_Supplement), 1271-1271, 2016 | 3 | 2016 |
| Aging-associated epigenetic reprogramming alters the germinal center reaction and targets pathways related to lymphomagenesis R Marullo, MV Revuelta, W Béguelin, J Lara-Garcia, L Cerchietti Blood 138, 676, 2021 | 2 | 2021 |
| Development of a Novel Class of Microtubule Destabilizing Agents with Selectivity Against Diffuse Large B-Cell Lymphoma (DLBCL) with B-Cell Receptor (BCR) Activation BP Gresely, F de Asís Balaguer, MG Cardenas, MV Revuelta, MNC Vidal, ... Blood 130, 2546, 2017 | 2 | 2017 |
